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SUMMARY
A replication study of a previous genome-wide asso-
ciation study (GWAS) suggested that a SNP linked to
the POLB gene is associated with systemic lupus
erythematosus (SLE). This SNP is correlated with
decreased expression of Pol b, a key enzyme in the
base excision repair (BER) pathway. To determine
whether decreased Pol b activity results in SLE, we
constructed a mouse model of POLB that encodes
an enzyme with slow DNA polymerase activity. We
show that mice expressing this hypomorphic POLB
allele develop an autoimmune pathology that
strongly resembles SLE. Of note, the mutant mice
have shorter immunoglobulin heavy-chain junctions
and somatic hypermutation is dramatically in-
creased. These results demonstrate that decreased
Pol b activity during the generation of immune diver-
sity leads to lupus-like disease in mice, and suggest
that decreased expression of Pol b in humans is an
underlying cause of SLE.
INTRODUCTION
Base excision repair (BER) functions during class switch recom-
bination (CSR) and somatic hypermutation (SHM) (for a review,
see Alt et al., 2013). Although BER ismainly known for its function
in the repair of at least 20,000 endogenous base lesions per hu-
man cell per day (Barnes and Lindahl, 2004), it appears to have
been co-opted from this role to act in the generation of antibody
diversity (for a review, see Di Noia and Neuberger, 2007). DNA
polymerase beta (Pol b) is a key protein in the BER pathway,
where it repairs single-strand breaks. Deletion of the POLB
gene from mice results in embryonic lethality (Gu et al., 1994).
In a large-scale replication study based upon a previous
genome-wide association study (GWAS) of SLE in the Han Chi-
nese population, association evidence for rs12676482 with sys-
temic lupus erythematosus (SLE) was replicated independently
in two large cohorts (Sheng et al., 2011). The significance of
this lies in the fact that rs12676842 is a SNP in the noncoding re-
gion adjacent to the POLB gene on 8p11.21. Of note, the lupus-
associated SNP rs12676482 is in perfect linkage disequilibrium
with rs2272733, which is highly correlated with decreased
POLB expression (Zeller et al., 2010). This suggests that low
Pol b activity is an underlying cause of SLE. We reasoned that
mice expressing a slow Pol b mutant polymerase, such as the
Y265C hypermorphic allele, would be an excellent model to
test the hypothesis that limiting the levels of active Pol b leads
to SLE. The Y265C mutant of POLB encodes a protein that
synthesizes DNA significantly more slowly than wild-type (WT)
Pol b (Washington et al., 1997). Therefore, we constructed a
POLBY265C/C mouse model using targeted gene disruption (Sen-
ejani et al., 2012). We demonstrate that these mice exhibit
several pathologies associated with SLE. In addition, our strat-
egy allowed us to define the contributions of Pol b during V(D)J
recombination and SHM. Importantly, our studies suggest that
an imbalance of error-prone and error-free break repair during
V(D)J recombination and SHM results in autoimmune disease.
RESULTS
POLBY265C/C Mice Have Pathologies Resembling SLE
We previously constructed the POLBY265C/C mouse model using
targeted gene disruption (Senejani et al., 2012). Observation of
the mice as they aged revealed an intriguing set pathologies
resembling SLE. The POLBY265C/C and POLBY265C/+ mice
exhibited an increased prevalence of dermatitis (Figures 1A
and S1). Dermatitis is a major manifestation of SLE in humans
(Norris and Lee, 1985) and is also observed in the SLE-prone
MRL/lpr lupus-like mouse model (Furukawa et al., 1984). The
POLBY265C/+ and POLBY265C/C mice exhibited significantly
increased levels of antinuclear antibodies (ANAs) in their blood
sera compared with WT mice, and the ANA levels continued to
rise over the lifetime of the mice (Figure 1B).
Besides ANA, another hallmark feature of SLE is glomerular
nephritis (Radic et al., 2011), which results from the formation
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of immune complexes on the kidneys. The POLBY265C/+ and
POLBY265C/C mice developed significantly increased levels
of glomerular nephritis compared with WT mice (Figure 1C).
By 12 months of age, we observed increased levels of immuno-
globulin G (IgG) localized to the glomeruli of the POLBY265C/C
mice versus WT controls (Figure 1E). Approximately 70% of
thePOLBY265C/+ andPOLBY265c/c mice exhibited cervical lymph-
adenopathy (Figures 1F–1G)with significant infiltration of T andB
lymphocytes (Figure S2), which are recognized symptoms of
SLE (Jonsson et al., 1987; Lavoie et al., 2011). In contrast, few
of their WT siblings had enlarged cervical lymph nodes. Several
of the mutant mice also exhibited enlarged salivary glands that
had infiltrating lymphocytes, which were predominantly T and
B cells (Figure S3). In combination, our results are consistent
with the interpretation that expression of a low-activity Pol b
variant leads to lupus-like disease in mice.
Figure 1. POLBY265c/c and POLBY265c/+ Mice Exhibit Multiorgan Symptoms of SLE
(A) Levels of lupus-like dermatitis are increased significantly in POLBY265c/c and POLBY265c/+ mice compared withWTmice as themice age. Shown are curves for
each genotype (POLB+/+, POLBc/+, and POLBc/c) representing the percentage of mice with lupus-like dermatitis.
(B) POLBY265c/c and POLBY265c/+ mice have higher levels of ANA than WT mice. Shown above the graph is an example of immunofluorescence intensity in 12-
month-old mutant mice compared with their WT littermates and MRL/lpr mice. Note that the fluorescence pattern observed in the MRL/lpr mice differs from that
observed in the POLBY265c/c and POLBY265c/+ mice. In the graph, levels of ANA were quantified from several mice (WT, blue squares; c/+, red circles; c/c, green
triangles) at various ages. In brief, ANA was tested by immunofluorescence using human epithelial (HEp-2) cells in 12-well slides (Diasorin). For each run, 1:50
diluted sera were used in a screening investigation. Samples from mice with high and low ANA scores were used on the same slide to confirm the sensitivity and
specificity of the test during each scoring.
(C) POLBY265c/c and POLBY265c/+ mice exhibit increased severity of glomerular nephritis compared with WTmice. The severity of kidney lesions was scored from
0 to 3 for normal, mild, moderate, or severe, respectively. For each mouse, more than ten glomerular, tubular, or interstitial areas were evaluated and scored for
glomerular cellularity, infiltrating leukocytes, severity of tubular lesions, mesangial matrix expansion, crescent formation, and interstitial mononuclear cell
infiltrates in the medulla and cortex. Lesion scores for each mouse were calculated as the mean of the summed individual scores from each evaluated factors.
(D) Examples of renal disease in POLBY265c/c mice compared with WT. The black arrow points to mesangial hypercellularity. The white arrow denotes basement
membrane thickening, and white arrowheads indicate glomerular crescents. The gray arrow denotes deposits of antibodies, and the black arrow indicates
shrunken glomeruli in the outer cortex.
(E) The kidneys of POLBY265c/c mice exhibit significantly more intense IgG staining than those of WT mice.
(F) POLBY265c/c mice exhibit significantly increased levels of cervical lymphadenopathy compared with WT mice.
(G) Examples of enlarged cervical lymph nodes in POLBY265c/c and POLBY265c/+ mice compared with the normal nodes shown in the WT mouse. Arrows point to
the cervical lymph nodes.
The error bars represent the SEM for the results of at least three experiments, and p values were calculated using the unpaired t test.
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The CDR3 Junctions of the Heavy Chains Are Short in
POLBY265c/c Mice
To determine whether the process of V(D)J recombination was
altered in our mice, we sequenced the V-D and D-J junctions
of T and B cell receptors from the WT and POLBY265C/C mice,
and found that the B cells derived from mutant mice had shorter
CDR3 junctions in the Ig heavy chain compared with those from
the WT (Figures 2A, 2B, and S4). The majority of CDR3 junctions
in the POLBY265C/C mice were 31–35 base pairs in length,
whereas they were 41–45 base pairs in the WT mice (Figure 2A),
withmanymore unidentifiable D regions in themutant versusWT
mice (Figure 2C; Bertocci et al., 2006). The lengths of N/P
additions between the rearranged V andD segments were signif-
icantly shorter in the POLBY265C/C mice than in WT controls (p <
0.05; Figure 2D). No significant differences in length of the Ig light
chain junctions or the T cell receptors were observed (data not
shown). Thus, the slow polymerase activity of the Y265C variant
leads to fewer N/P additions between the rearranged V and D
segments of the Ig heavy chain.
CSR Is Similar in WT and POLBY265C/C Mice
Previous work suggested that Pol b functions in CSR (Wu and
Stavnezer, 2007). In that study, fetal liver cells isolated from
WT or POLBD/D mice were transplanted into irradiated hosts,
and in vitro CSR assays showed slight increases in switching
to IgG2a. As shown in Figure 3, we observed no differences in
the levels of IgG1, IgG2a, IgG2b, or IgG3 in the POLBY265C/C
versus WT mice, suggesting that CSR is not altered in the Pol
b mutant mice.
The Rate of SHM Is Significantly Higher in POLBY265C/C
Mice
SHM is a co-opted form of BER and occurs in later stages of B
cell development within the germinal center (GC) (Di Noia and
Neuberger, 2007; Maul and Gearhart, 2010; Victora and
Nussenzweig, 2012). SHM occurs primarily in the variable region
of the Ig heavy chain, which results in the production of high-
affinity antibodies (Di Noia and Neuberger, 2007; Liu and Schatz,
2009; Rajewsky et al., 1987; Weigert et al., 1970). Because
Y265C Pol b is a very slow BER polymerase, gaps in DNA that
are generated during SHM are unlikely to be filled efficiently
during SHM in the POLBY265C/C mice. To determine whether
this was the case, we characterized SHM in the JH4 intron down-
stream of VHJ558-JH4 using PCR followed by DNA sequencing.
Our analysis revealed that the POLBY265C/C mice exhibited a
significantly increased frequency of SHM compared with WT
(Figures 4A and 4B). The frequencies of transversions at GC
Figure 2. VDJ Recombination Is Aberrant in
POLBY265c/c Mice
(A) PCR-amplified products from B220+ IgM
bone marrow and splenic cell genomic DNA
of 3- to 4-week-old POLB+/+ and POLBC/C mice
were cloned and sequenced. The lengths of
the CDR3 sequences as a function of the per-
centage of sequences with particular lengths
are plotted in the graph. Note that the majority
of CDR3 sequences from the POLBY265c/c mice
have a length of 31–35 bases, whereas the CDR3
region of WT mice is 41–45 bases in length.
At least three mice of each genotype were
characterized.
(B) The table shows the ranges of lengths of the
CDR3 regions from spleen and bone marrow
found in WT and POLBY265c/c mice.
(C) The percentage of D regions in the POLBC/C
mice that were unidentifiable was significantly
greater than that observed in WT controls. D re-
gions were identified on the basis of six contig-
uous nucleotides.
(D) The average length of N/P-nucleotide addition was reduced in POLBC/C mice. The allocation of N/P nucleotides was based on the known sequences of the
germline elements. The average length of the N/P region between the rearranged V and D junction (N1) was significantly shorter in POLBC/C mice compared with
WT controls. The N/P region between the rearranged D and J junction (N2) was not significantly different between POLB+/+ and POLBC/C mice.
The error bars represent the SEM for the results of at least three experiments, and p values were calculated using the unpaired t test.
Figure 3. CSR Is Normal in POLBY265c/c Mice
Naive splenic B cells were isolated from spleens of three to five POLBY265C/C
and WT control mice, and induced in vitro with either LPS to induce
switching to IgG1, LPS with IL-4 to induce switching to IgG3, LPS with INFg
to induce switching to IgG2a, or LPS with TGFb to induce switching to IgG2b.
No significant change in CSR in the B cells was observed between the
POLBY265C/C and WT mice.
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base pairs were most significantly increased (Figures 4A and
4C), although increases in mutations at A:T base pairs were
also elevated. The POLBY265C/C mice also displayed increased
levels of mutation in the hotspot motifs that are targeted by acti-
vation-induced cytidine deaminase (AID; Figure 4D).
Increased Numbers of GCs in POLBY265C/C Mice
The increased frequencies of SHM in POLBY265C/C mice promp-
ted us to determine whether these mice possess increased
numbers of GCs, as is often found in lupus-prone mice. The
POLBY265C/C mice exhibited increased numbers of GCs in
spleen (Figure 5A). This observation is supported by a fluores-
cence-activated cell sorting (FACS) analysis that showed
elevated numbers of GC B cells and follicular T helper cells
(TFH) in the spleens of POLB
Y265C/C mice compared with WT
mice (Figure 5B). However, there were significantly higher levels
of apoptosis in the spleens of the POLBY265C/C mice compared
with WT mice (Figure 5C). To determine whether cell death
was occurring in the GCs, we performed a terminal deoxynu-
cleotidyl transferase dUTP nick end labeling (TUNEL) analysis.
The POLBY265C/C mice exhibited significantly increased levels
of TUNEL-positive cells that mostly overlapped with CD4 T help-
er cells (Figures 5D and 5E).
DISCUSSION
Here, we show that mice carrying the Y265C hypomorphic allele
of POLB develop several SLE-associated pathologies, suggest-
ing that low activity of Pol b leads to SLE. Our results suggest that
this phenotype arises as a result of aberrant V(D)J recombination
and a high frequency of SHM. Our findings strongly implicate Pol
b as a critical player in both V(D)J recombination and SHM.
Figure 4. The Rate of SHM Is Increased in POLBY265c/c Mice
(A) Products were amplified using PCR and genomic DNA isolated from B220+ PNAhigh Peyer’s patches of 3- to 5-month-old POLB+/+ and POLBC/C mice. These
products were cloned and sequenced. SHM results show that the overall frequencies are increased in the POLBY265c/c mice compared with the WT.
(B) For SHM, the 344 nucleotides downstream of the JH4 gene region of rearranged VDJ segments on the heavy-chain locus of the VHJ558 gene were PCR
amplified and sequenced. The numbers of mutations versus the total length of DNA sequences and the mutation frequency were analyzed in three mutant mice
and three age-matched WT animals with the use of SHMTool, which is a webserver for comparative analysis of SHM data sets. At the center of the pie chart is
shown the numbers of clones analyzed for each genotype. Segments show the percentage of each clone that contained a defined number of mutations, and
these are indicated with different colors.
(C) All types of mutations are increased (p = 3.7 3 1018) in the JH4 intron from the POLB
Y265c/c mice, but the types of mutations that are most significantly
increased are transversions at GC base pairs (p = 2.83 108), followed by transitions at GC (p = 7.03 107), transversions at AT (p = 33 105), and transitions at
AT base pairs (p = 0.0029). At least three mice of each genotype were used for these experiments.
(D) Amino acid motifs shown on the x axis are where many of the SHMmutations occur in the POLBY265c/c mice. Mutations arise predominantly in GYW (p = 7.43
105), RGYW (p = 0.0003), and DGYW (p = 7.4 3 105), which are the motifs in which deamination catalyzed by AID occurs.
The error bars represent the SEM for the results of at least three experiments, and p values were calculated using the unpaired t test.
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Processing by POLBY265C/C Leads to Short CDR3
Junctions During V(D)J Recombination
SLE is a classic autoimmune disease that is characterized by
the production and circulation of ANAs that participate in tissue
destruction. We have shown that POLBY265C/C mice produce
significantly higher levels of ANA than WT mice by 6 months
of age, and that the levels of ANA continue to increase over the
lifetime of the mice, leading to glomerulonephritis, dermatitis,
and cervical lymphadenopathy. Because the production of
ANA is a major causative factor of SLE, and because DNA repair
proteins are central players in development of the lymphocyte
repertoire, we investigated the potential role of Pol b Y265C in
that process, starting with VDJ recombination. We showed
that the CDR3 junctions of IgH, especially the N/P additions
between the V and D fragments, are shorter in the
POLBY265C/C mice than in the WT. A model depicting the role
of Pol b Y265C in joining the V and D fragments is shown in Fig-
ure 6. After cleavage by RAG proteins, hairpins are formed and
cut by the Artemis endonuclease. If the incision by Artemis
results in staggered ends, as shown in Figure 6, a DNA polymer-
ase fills the gap, followed by ligation. When Y265C is present,
gap filling is slow and inefficient, leading to nuclease activity
that results in a shorter CDR3 junction. We suggest that Y265C
Pol b acts in a dominant-negative manner by not permitting
access of other DNA polymerases, including Pol l and Pol m,
to the gapped DNA, eliminating functional redundancy. We point
out that short gaps are the optimum DNA substrate for Pol b
(Chagovetz et al., 1997). Previous work using mice deleted of
the POL L gene provided evidence that Pol l processes this
gap (Bertocci et al., 2006). Characterization of V(D)J recombina-
tion in the absence of Pol b was not possible because POLBD/D
mice do not survive past birth. In vitro reconstitution studies (Ma
et al., 2004) did not demonstrate a role for Pol b. However, in
these studies, Pol b was never assessed in combination with
terminal transferase, Pol l, and/or Pol m, so its participation
may not have been detected.
The Presence of POLBY265C/C Does Not Alter CSR
CSR occurs by a process of intrachromosomal deletion that
is initiated by the formation of double-strand breaks (DSBs).
DSB formation is initiated when AID deaminates cytosine on
both strands of the DNA in the switch regions. The resulting uracil
residues are recognized and excised by uracil DNA glycosylase
(UNG), followed by apurinic/apyrimidinic endonuclease 1 (APE1)
incision (for a review, see Stavnezer et al., 2008). If the uracils are
clustered and on opposite strands of the DNA, incision by APE1
will result in DSBs. Alternatively, the U:G mispair will be recog-
nized by mismatch repair proteins that recruit exonuclease I
(Exo I) to the DNA. Exo 1 excision opposite a nick that results
from incision by APE1 can also result in a DSB. Therefore, gap
filling by Pol b can prevent the formation of DSBs during CSR,
as suggested previously when a slight increase in switching to
Figure 5. POLBY265c/c Mice Have Increased
Numbers of GCs Compared with WT Mice
(A) Spleens of three or four 5-month-old mice were
frozen with OCT compound, prepared as a frozen
section, and stained overnight at 4C for confocal
analysis. PNA-positive GCswere counted per field
(253). The graph compares the numbers of GCs
in POLBY265c/c and WT mice, and the image
depicts an example of multiple GCs in the spleen
of a POLBY265c/c mouse.
(B) Examples of FACS-sorted splenic cells. For
flow cytometry, splenic cells from three to five
5-month-old mice were processed and stained
with anti-mouse antibodies (eBioscience) as
described in the Supplemental Experimental
Procedures. Top: GC B cells from a 5-month-old
mouse were CD19+IgD-lo gated, followed by
gating for CD95 Gl7 double-positive cells (WT
(+/+) is on the left and c/c is on the right). Bottom:
TFH cells were CD4+ CD44-lo gated, followed by
gating for CXCR5 PD-1 double-positive cells.
(C) Graph showing the percentage of TUNEL-
positive cells from POLBY265c/c and WT spleens,
which is representative of at least three mice of
each genotype.
(D) Spleen frozen sections were stained overnight
at 4C for confocal analysis. The image represents
an example of GCs in the spleens of POLBY265c/c
and WT mice. PNA-positive GCs are shown in
green (fluorescein isothiocyanate), CD4-positive
T helper cells are shown in blue (aCD4-Cy5), and
TUNEL-positive cells are shown in red.
(E) Graph showing the percentage of TUNEL-
positive cells in the GCs of POLBY265c/c and WT
mice, which is representative of eight to ten GCs of
two to three mice of each genotype.
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IgG2a was observed in POLBD/D B cells (Wu and Stavnezer,
2007). In contrast, we observed no significant increases in
CSR in the B cells from POLBY265C/C mice that were induced
to switch in vitro. One explanation for our results is that the
presence of the Y265C Pol b polymerase prevents significant
DSB formation through the APE1 pathway because it has
the ability to bind to and slowly fill the DNA gap. This suggests
that mismatch repair could constitute a major DSB-formation
pathway during CSR. The binding of Y265C Pol b to the 30OH
of the gap could also prevent further processing by nucleases.
Lack of Gap Filling by Y265C Pol b Results in Increased
SHM
We showed that the frequency of SHM in the POLBY265C/C mice
was significantly increased over that of WT mice, and we
observed increases predominantly in transversions at AID hot-
spots. These findings are consistent with the idea that Pol b plays
a critical role in maintaining a balance between error-free and er-
ror-prone repair during SHM. Amodel for the role of Pol b Y265C
is presented in Figure 7. After AID deaminates cytosine to uracil,
there are three pathway choices. If replication occurs, transitions
are observed at AID deamination hotspots. If the U:G mismatch
is recognized by the mismatch repair pathway, mutations at A:T
base pairs are observed. Alternatively, UNG removes uracil.
Bypass of the resulting AP site by a translesion polymerase leads
to transversions at the AID hotspot. However, should APE1
incise the backbone, a single nucleotide gap could be filled in
by a translesion polymerase, resulting in transversions, or the
gap could be filled in by Pol b in the canonical BER pathway,
resulting in error-free repair. We suggest that gap filling is slow
in the presence of Y265C Pol b, which would eventually lead to
gap filling by TLS polymerases and the transversions we observe
during SHM. Alternatively, Y265C could fill the gap in an error-
prone manner. We do not favor this explanation, however,
because we do not observe increased levels of transversions
at G:C base pairs in in vivo or in vitro studies with Y265C Pol b
(Clairmont et al., 1999; Opresko et al., 1998; Washington et al.,
1997). Another possibility is that many gaps remain unfilled,
eventually resulting in cell death, consistent with our observation
of increased TUNEL foci in the spleens of the POLBY265C/C mice.
We note that in addition to increased levels of mutation at G:C
base pairs, we also observe increases of A:T mutations. This
could occur if the unfilled gap is bound by a nuclease, which
would enlarge the gap. Filling of the larger gap by a translesion
polymerase would lead to mutations at A:T base pairs.
Our findings are significant because they show that a balance
between error-prone and error-free repair during SHM is critical,
and that Pol b plays an important role in maintaining this bal-
ance. Our results suggest that too much mutagenesis during
SHM has the potential to lead to autoimmune disease. In sup-
port of this suggestion, reversion of the mutations produced
during SHM results in antibodies that no longer have antinuclear
activity, suggesting that SHM itself is one mechanism for
creating autoreactive antibodies (Guo et al., 2010; Wellmann
et al., 2005).
Selection in the GC?
Not only do the POLBY265C/C mice have increased numbers of
GCs, but the GCs exhibit significantly increased TUNEL staining
compared with WT mice. Gaps that arise during SHM or during
the repair of oxidative damage that occurs during the prolifera-
tion of B cells in the GC may not be filled in efficiently by
Y265C Pol b, leading to cell death. The presence of apoptotic
or dying cells in the GCs could result in the release of antigen,
resulting in positive selection of GC B cells that produce auto-
antibodies. This suggestion is supported by studies showing
that mice with defective clearance of apoptotic cells develop
lupus-like disease (Bickerstaff et al., 1999; Hanayama et al.,
2004; Napirei et al., 2000). We suggest that in POLBY265C/C
mice, the large amount of apoptotic cells in GCs could over-
whelm the apoptotic clearance machinery, thereby escaping
clearance and being used for positive selection of autoreactive
B cells. It is also possible that the increased SHM generates
autoreactivity by targeting IgG-expressing memory B cells reen-
tering the GC as a result of chronic exposure to self-antigen
(Ko¨hler et al., 2008; Meffre and Wardemann, 2008). Finally, it is
possible that extrafollicular B cells could play a role in the gener-
ation of autoantibodies, as described for the MRL/lpr mouse
model of SLE (Teichmann et al., 2010).
Aberrant DNA Repair and Autoimmunity
Previous work has shown that mutations of the TREX1 DNA
repair gene in humans are also associated with SLE (Stetson
et al., 2008), but there is no evidence that these proteins act
during the immunological processes of V(D)J, CSR, and SHM.
Our findings demonstrate that a balance of hypermutation and
Figure 6. Model of Aberrant V(D)J and SHM in POLBY265c/c Mice
Y265C Pol b promotes deletion during joining of the V and D fragments. This
cartoon depicts joining of the V to the D fragment. After the Rag proteins cleave
the DNA, hairpins form. Artemis nicks the hairpins, which sometimes results in
a substrate with DNA gaps. WT Pol b or other X family polymerases fill the
gaps. However, in the presence of the slow Y265C Pol b polymerase, gaps are
filled inefficiently, which can result in nuclease activity leading to deletions and
shortening of the CDR3 junction.
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error-free BER during SHM is critical for the prevention of auto-
immune disease. Our results do not rule out the possibility of
other mechanisms that are not B cell intrinsic. For example,
many cell types utilize Pol bY265C during BER, and the accumu-
lation of BER intermediates in these cells could lead to alter-
ations in a variety of tissues, such as the gut epithelial barrier
(including stem cells). Any resulting mucosal alterations could
drive expansion of autoreactive clones. The results of our study
suggest that mutations in DNA repair genes associated with
immunological processes could lead to the development of
autoimmune disease, including SLE.
EXPERIMENTAL PROCEDURES
Strain and Genotyping of Mice
Hybrid (129/Sv and C57BL/6) mice of both sexes were used for this study. All
work with mice was carried out with oversight by the Yale University Institu-
tional Animal Care and Use Committee.
Skin Histology
Skin tissues were fixed in histological 10% formalin solution fixative (Sigma-
Aldrich) and embedded in paraffin. Skin sections were analyzed by a
dermatopathologist.
Detection and Scoring of ANAs
ANAs were tested by immunofluorescence using human epithelial (Hep-2)
cells on 12-well slides (Diasorin).
Histology and Scoring of Kidney Lesions
Tissues frommice were isolated and fixed in histological 10% formalin solution
fixative (Sigma-Aldrich), and embedded in paraffin. Hematoxylin and eosin-
stained tissueswere evaluated as described in the Supplemental Experimental
Procedures.
Immunohistochemistry
Details regarding immunohistochemistry are described in Supplemental
Experimental Procedures.
Analysis of SHM
Genomic DNA was extracted from B220+PNAhigh cells obtained from Peyer’s
patches of two nonimmunized mice that were 3.5–5 months of age, and
analyzed as described previously (Jolly et al., 1997; McDonald et al., 2003;
Maccarthy et al., 2009).
Preparation of Genomic DNA, PCR Amplification, and Analysis of
VDJ Recombination Sequences
Genomic DNA was prepared from B220+ IgM cells from spleen and bone
marrow of three to five 3-week-old mice and analyzed as described in Supple-
mental Experimental Procedures (Gilfillan et al., 1993; Komori et al., 1993).
ELISA
ELISA 96-well plates were coated overnight at 4C with the appropriate anti-
sera and analyzed as described in Supplemental Experimental Procedures.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and four figures and can be found with this article online at http://dx.doi.org/
10.1016/j.celrep.2013.12.017.
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